Big boost to India's Covid vaccination drive: Covaxin shows 81% interim efficacy
  • 3 years ago
In a big boost to India's nationwide Covid-19 vaccination drive, Bharat Biotech announced that the interim analysis of Covaxin show the vaccine demonstrates 81 per cent interim efficacy.
Recommended